Option chain shows key data for Bank of Ireland Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bank of Ireland Group.

Bank of Ireland Group (OTC:BKRIF) Stock, Option Chain

Bank of Ireland Group PLC is an Irish financial services group operating mostly in Ireland and the United Kingdom. Services include mortgages, business, and corporate lending, term loans, leasing, foreign exchange, life assurance, and pension products, among others. The bank's trading divisions include Retail Ireland, Wealth and Insurance, Retail UK, Corporate and Treasury (C&T) and Group Centre. The bank generates the majority of its revenue from Retail Ireland serves consumer and business customers across a broad range of segments and sectors. Revenue is also derived from fees for a range of banking and transaction services. The bank has access to distribution in the United Kingdom via its relationship as a financial services partner with the nation's post office.

Biotech

Penny Stocks

Global

Trading Ideas

General

BKRIF

RYAAY

TRIB

For many people, St. Patrick’s Day means a corned beef and cabbage dinner, a pint of Guinness and watching “The Quiet Man” for the 100th time.

For investors seeking to add a breath of fresh Eire in their portfolios might want to consider taking a second look at some major Irish companies trading on the U.S. exchanges.

5 Irish Stocks To Buy For St. Patrick&#39;s Day

News

Movers & Shakers

Intraday Update

Markets

Movers

AACAY

AAWW

ABEO

ACER

ACRGF

ACRS

ADAP

AGGZF

AGRO

AGRPY

AHKSY

AIFLY

AMSYF

AOBC

APNHY

APVO

ARLP

ARREF

ASIX

ASNA

AUTL

AWLCF

AZZUF

BACHY

BBAR

BBBY

BBVA

BELFA

BHKLY

BIIO

BKRIY

BLCM

BrightSphere Investment Group plc Ordinary Shares

BSIG

BURG

BWFG

CAAP

CAKE

CALX

CEIX

CEPU

CHDGF

CHKDG

CHYHY

CICOF

CINR

CISN

CLNC

CLPHF

CNKEF

CNONF

COMM

CPCAY

CPRI

CPYYY

CRESY

CTJHY

CTRA

CTSO

CTTAY

Changyou Limited American Depositary Share

CYOU

DAIO

DDAIF

DESP

DFIN

DLTH

DMLRY

DNJR

DNKEY

DSEEY

DSFGY

DTNOF

EBIX

ELIO

EONGY

Stocks That Hit 52-Week Lows Of Monday

ABBV

ABMD

ACGBF

ADMP

AERI

AGTK

AIBGY

ALKM

ALNA

ALSWF

AMAG

ANGI

APGMF

APOP

ARCH

ARLO

ASRT

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATHOF

ATRA

ATVK

AVNS

AXGN

AXVEF

AZRX

BAFYY

BBCP

BBVXF

BCDA

BCEFF

BCEL

BCYC

BDVSY

BEDU

BFIN

BICEF

BIDU

BIOAF

BIREF

BJRI

BKKLY

BLMN

BLRX

BNDSF

BNEFF

BPAQF

BPFH

BRKMY

BRTX

BTHE

BUDZ

BXEFF

BZLFY

CADE

CAIXY

CARB

CARCY

CARG

CARS

Stocks That Fell Through 52-Week Lows Wednesday

BANK IRELAND GRP EUR1 ORD by Bank Ireland Group PLC

Bank of Ireland Group PLC

Zeta Global Holdings Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>), a marketing technology company specializing in AI-powered marketing solutions has outperformed the NYSE Composite index in 2024, while its peers have underperformed the market. Based on its fundamental and technical analysis, should you buy, sell, or hold the stock? Here&#8217;s what analysts are saying. 
Shares of Zeta were up 1.23% at $18.97 per share as of Thursday&#8217;s close. The stock was up 125.83% this year outperforming NYSE Composite, which rose by 14.98%.
Its peers, Freshworks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) was down 27.26%, and Temenos ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TMSNY#OTC">TMSNY</a>) was down 21.52% in the same period.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison--1024x576.png" alt="" class="wp-image-708544" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison--1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison--300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison--768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison--1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010414/Zeta-peer-comparison-.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The technical analysis of daily moving averages indicates a short-term bearish trend.
The stock ended at $18.97 apiece on Thursday. This was below its eight and 50-day simple moving average of $19.52 and $21.69, respectively. However, as per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data, its current stock price was also lower than the 50-day moving average of $24.42, and its 200-day moving average of $24.42.
This implies that the stock is in a downtrend. On the other hand, the relative strength index of 38.38 suggests the stock&#8217;s movement is moderately oversold but still in the neutral zone.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart-1024x576.png" alt="" class="wp-image-708548" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010622/Zeta-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/24/12/42680125/nvda-could-go-up-to-170-in-q1-after-breaching-145-level-as-traders-turn-bullish-on-jensen-huangs-ai-giant">NVDA Could Go Up To $170 In Q1 After Breaching $145 Level As Traders Turn Bullish On Jensen Huang&#8217;s AI Giant</a> 
<h3 class="wp-block-heading">Two Of Zeta&#8217;s Clients Merge</h3>
Zeta Global stands to benefit from Omnicom&#8217;s acquisition of Interpublic. David A. Steinberg, the co-founder, chairman, and CEO of Zeta, in a statement on Dec. 9 said that &#8220;We are proud of our extensive relationships with the top Holdcos, including both Omnicom and IPG, and believe that today's announcement is a positive one for the industry and Zeta. Like everyone else, we will be watching closely as this progresses and offer support as needed.&#8221;
During its investor summit, Zeta said it can leverage the combined entity&#8217;s vast data infrastructure and enhanced financial strength. This presents opportunities for Zeta to deepen AI-powered customer insights, expand scale and reach and accelerate growth.
<h3 class="wp-block-heading">New Acquisition By Zeta</h3>
Zeta Global&#8217;s acquisition of LiveIntent is projected to contribute "Vast data assets, direct channel capabilities and premium publisher network to the Zeta Marketing Platform. The integration of LiveIntent into the ZMP will expand gross margins while accelerating the shift of our revenue derived from agency customers to direct channels,&#8221; added Steinberg in a statement dated Oct. 8, 2024. This data foundation will further position Zeta to capitalize on the combined Omnicom-Interpublic entity, offering solutions to this major client segment.
<h3 class="wp-block-heading">ZETA's Estimated Topline And Bottomline</h3>
Benzinga&#8217;s <a href="https://www.benzinga.com/quote/ZETA/earnings">estimate</a> for the fourth quarter revenue is pegged at $265.73 million, suggesting 26.34% growth from last year&#8217;s topline of $210.32 in the same quarter.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/ZETA/earnings"><img loading="lazy" decoding="async" width="1024" height="415" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010715/Zeta-global-revenue-1024x415.png" alt="" class="wp-image-708549" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010715/Zeta-global-revenue-1024x415.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010715/Zeta-global-revenue-300x122.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010715/Zeta-global-revenue-768x311.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010715/Zeta-global-revenue.png 1194w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The consensus <a href="https://www.benzinga.com/quote/ZETA/earnings">estimate</a> for earnings in the fourth quarter is pegged at 21 cents per share, as compared to 16 cents in the same quarter of the previous fiscal, suggesting a 31.25% increase from the prior year&#8217;s actual.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/ZETA/earnings"><img loading="lazy" decoding="async" width="1024" height="411" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010112/Zeta-global-EPS-1024x411.png" alt="" class="wp-image-708538" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010112/Zeta-global-EPS-1024x411.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010112/Zeta-global-EPS-300x120.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010112/Zeta-global-EPS-768x308.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27010112/Zeta-global-EPS.png 1213w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">Zeta Has Higher Liquidity To Meet Obligations</h3>
The company had a current ratio of 3.319 at the end of the third quarter, exceeding the industry average of 2.16, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data. This ratio, indicating a robust ability to meet short-term obligations, has surged 67.7% from the previous quarter.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42681797/should-you-buy-or-sell-this-nvidia-rival-analysts-weigh-in-as-technicals-signal-a-downtrend">Should You Buy or Sell This Nvidia Rival? Analysts Weigh In As Technicals Signal A Downtrend</a> 
What Are Analysts Saying: According to <a href="https://www.benzinga.com">Benzinga</a>, Zeta has a consensus &#8216;hold&#8217; with a price target of $32.59 based on the ratings of 17 analysts.
The highest price target out of all the <a href="https://www.benzinga.com/quote/ZETA/analyst-ratings">analysts</a> tracked by Benzinga is $45 issued by Craig-Hallum with a &#8216;buy&#8217; rating on Nov. 12, 2024. Analyst Jason Kreyer highlights Zeta Global&#8217;s strong performance, driven by the successful LiveIntent acquisition and cross-selling opportunities. Analyst is positive on the deepening penetration within the existing $100 billion plus customer base by replicating successful high-spend customer relationships.
Goldman Sachs analyst Gabriela Borges initiated coverage on Zeta with a &#8216;neutral&#8217; rating and announced a price target of $30 apiece. The note highlighted key medium-term risks. Including a possibility of its proprietary data&#8217;s value erosion as data accessibility and evolving consumer preferences may diminish, requiring continuous innovation. Strong 2024 performance, partly driven by one-time events, may make year-over-year comparisons challenging in 2025. Also, according to the analyst stricter privacy laws pose a long-term risk to Zeta&#8217;s data-driven business model, as evidenced by recent underperformance amid industry scrutiny.
The lowest target price was maintaining a &#8216;neutral&#8217; from Credit Suisse was adjusted to $9.5 from $12 per share on Aug. 4, 2022. The average price target of $38.67 between Goldman Sachs, RBC Capital, and Needham implies a 105.13% upside for Zeta.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/ZETA/analyst-ratings"><img loading="lazy" decoding="async" width="948" height="361" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27005852/Zeta-ANR.png" alt="" class="wp-image-708535" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27005852/Zeta-ANR.png 948w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27005852/Zeta-ANR-300x114.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27005852/Zeta-ANR-768x292.png 768w" sizes="(max-width: 948px) 100vw, 948px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025">S&amp;P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq&#8217;s Surge</a></li>
</ul>

Analyst Color

Equities

Long Ideas

Market Summary

Downgrades

Price Target

Technicals

Initiation

Reiteration

Analyst Ratings

FRSH

TMSNY

ZETA

Zeta Global Shares Beat Peers To Rise 125% In 2024: Breaking Down The Numbers

Chinese EV giant BYD Co Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) is reportedly offering discounts of up to 11.5% on its Song Pro DM-i and Qin Plus EV vehicle models.
What Happened: The Song Pro DM-i and the Qin Plus EV now have a starting price of 99,800 yuan, marking a discount of 11.5% and 9.1% from their price before the discount, Reuters reported. The discount is valid until Jan. 26.
BYD is China&#8217;s biggest EV seller and a major rival to American EV giant Tesla Inc. However, unlike Tesla, BYD makes both plug-in hybrid and battery electric vehicles, together referred to as new energy vehicles. 
Why It Matters: In the last quarter of 2023, <a href="https://www.benzinga.com/24/12/42680542/tesla-or-byd-which-ev-giant-will-sell-more-battery-electric-vehicles-in-q4">BYD sold 526,409 battery electric vehicles</a>, effectively replacing Tesla as the world's biggest seller of BEVs. Tesla in that quarter delivered just 484,507 units.
Tesla regained its position as the world's top seller of BEVs in the first quarter after selling 386,810 BEVs, 86,696 units more than BYD. Tesla kept up its lead in both Q2 and Q3. 
While it is unclear who will take the lead in the fourth quarter, both are trying to entice buyers with offers. Tesla is currently offering a discount of 10,000 yuan on the purchase of inventory <a href="https://www.benzinga.com/news/global/24/12/42681583/chinas-ev-industry-likely-to-outpace-us-and-allies-but-elon-musks-tesla-could-still-make-gains">Model Y vehicles in China</a>, its second-biggest market outside the U.S.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42668333/tesla-model-x-lucid-gravity-or-rivian-r1s-which-three-row-electric-suv-is-a-better-buy" target="_blank" rel="noreferrer noopener">Tesla Model X, Lucid Gravity Or Rivian R1S: Which Three-Row Electric SUV Is A Better Buy?</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

BYDDY

BYD Offers Discounts Of Up To 11.5% On Select EVs As Year End Nears

Reported Earlier, Castellum Plans Public Offering Of Common Stock

XCUR

Reported Earlier, Exicure Signs Deal With GPCR Therapeutics To Acquire Subsidiary And Advance Biotech Growth

<ul>
<li>HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia and Hypogammaglobulinemia</li>
<li>Administration of Recombinant Human Hyaluronidase Prior to Immunoglobulin Facilitates Subcutaneous Infusion of Larger Volumes, Potentially Reducing Frequency and Giving Patients More Flexibility</li>
<li>Approval Expands Takeda's Portfolio of Differentiated Immunoglobulin Therapies and Reflects the Company's Commitment to Bring High-Quality Plasma-Derived Therapies to Patients in Japan</li>
</ul>

Takeda Gains Approval For HYQVIA In Japan To Treat Immunodeficiency

<ul>
<li>VYVDURA&#xAE; now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP</li>
<li>argenx's VYVGART&#xAE; and VYVDURA portfolio approved in Japan for three indications – first country globally with access across three indications</li>
</ul>

ARGX

argenx Gets Approval For VYVDURA In Japan To Treat Chronic Inflammatory Demyelinating Polyneuropathy Patients

Nio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) brand Onvo said on Friday that it has delivered <a href="https://www.benzinga.com/tech/24/12/42681165/nios-onvo-brand-helps-spur-delivery-growth-with-cheaper-offering">20,000 units of its L60 SUV</a> within 100 days of commencing deliveries. 
What Happened: Onvo made the announcement via a post on the social media platform Weibo. 
Nio launched its family-oriented lower-priced EV brand Onvo in May this year. The company launched the L60 SUV on Sept. 19 and started deliveries on Sept. 28.
Now, merely a hundred days after launch, the company delivered 20,000 units.
The Onvo L60 is a mid-size electric SUV that starts at 206,900 yuan ($28,347) with the battery pack included, much lower than Tesla's affordable models Model 3 or Model Y in China.
Why It Matters: In September, Nio delivered 832 Onvo L60s despite having only a few selling days. In October, the first full month of sales, Onvo deliveries rose to 4,319. In November, L60 deliveries rose to 5,082. 
This implies that Onvo has sold 9,767 units of the L60 thus far in December, marking its highest monthly delivery total to date.
Nio, the company&#8217;s premium EV brand, <a href="https://www.benzinga.com/24/12/42260165/li-auto-xpeng-nio-heres-how-november-deliveries-of-chinese-ev-startups-stack-up">delivered just 15,493 vehicles in November</a> despite its longer lineup. Onvo, meanwhile, is closing in 10,000 deliveries in a month with just one vehicle model. At the current pace, Onvo is likely to take over Nio as the parent company&#8217;s best-selling brand. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42668333/tesla-model-x-lucid-gravity-or-rivian-r1s-which-three-row-electric-suv-is-a-better-buy" target="_blank" rel="noreferrer noopener">Tesla Model X, Lucid Gravity Or Rivian R1S: Which Three-Row Electric SUV Is A Better Buy?</a></li>
</ul>
Photo courtesy: Nio

Onvo Sells 20,000 EVs In 100 Days Of Launch, Gearing To Be Nio's Best-Selling Brand

Macro Economic Events

Econ #s

Economics

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Industrial Production (MoM) Preliminary For November -2.3% Vs. -3.4% Est.; 2.8% Prior

Reported Earlier, Japan Tokyo Core Consumer Price Index (YoY) For December 2.4% Vs. 2.5% Est.; 2.2% Prior

Strive Asset Management, a company co-founded by Vivek Ramaswamy, announced plans for an exchange-traded fund on Thursday that would seek exposure to convertible securities issued by companies investing in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: The proposed ETF, named the Strive Bitcoin Bond ETF, aims to expose investors to the growing &#8220;Bitcoin bond&#8221; market, leveraged by companies like MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) to fund Bitcoin acquisitions, an SEC <a href="https://www.sec.gov/Archives/edgar/data/1592900/000159290024002726/strivebitcoinbondetf485a.htm">filing </a>showed.
&#8220;Under normal circumstances, at least 80% of the notional exposure of the Fund (through securities and financial instruments) will be to Bitcoin Bonds,&#8221; the filing read.
Strive said that the fund will treat convertible debt as equity securities, despite the instruments having some attributes of debt securities.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42691548/floki-eyes-dogecoin-rivalry-with-second-meme-coin-exchange-traded-product">Floki Eyes Dogecoin Rivalry With Second Meme Coin Exchange-Traded Product</a>
Why It Matters: The filing comes amid a growing trend of companies issuing convertible bonds to support their Bitcoin purchase strategy. Michael Saylor-led MicroStrategy has been the market leader, <a href="https://www.benzinga.com/markets/equities/24/11/42186167/michael-saylors-microstrategy-convertible-notes-to-buy-bitcoin-offer-no-interest-so-why-are-investors-rushing-to-buy-them">issuing these bonds at 0% interest</a>.
A convertible note is a hybrid instrument that can be exchanged for equity in the company at a later date. The conversion feature of these notes eventually helps the debt holders to benefit from the equity upside on conversion. 
The strategy has drawn a fair share of criticism, with <a href="https://www.benzinga.com/24/11/42228264/crypto-analyst-flags-convertible-debt-induced-liquidation-risk-to-michael-saylors-microstrategy">analysts pointing out the risks</a> of debt buyers not converting to shares before maturity.
Meanwhile, popular cryptocurrency analyst James Van Straten noted that Strive&#8217;s filing meant &#8220;more vested interest&#8221; for Bitcoin to do well under the Trump administration.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Vivek Ramaswamy owns Strive with outside investment from the now Vice President J.D Vance. More vested interest for <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> to do well from the Trump Administration. <a href="https://t.co/iN4gQyi4ZN">https://t.co/iN4gQyi4ZN</a>
&mdash; James Van Straten (@btcjvs) <a href="https://twitter.com/btcjvs/status/1872369373878640870?ref_src=twsrc%5Etfw">December 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Strive founder Ramaswamy <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">was appointed</a> by President-elect Donald Trump to lead the new Department of Government Efficiency along with tech mogul Elon Musk.
Ramaswamy&#8217;s involvement in the cryptocurrency sector isn&#8217;t new. During his run for the Republican presidential nomination, Ramaswamy advocated for reducing the Securities and Exchange Commission&#8217;s reach and <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36637284/the-bitcoin-president-that-wasnt-what-the-crypto-community-is-saying-about-vivek-ramaswamy">providing clarity</a> in cryptocurrency regulation.
Price Action: At the time of writing, Bitcoin was exchanging hands at $96,007.97, down 2.65% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Photo: Gage Skidmore on flickr
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42690488/are-donald-trumps-ambitious-bitcoin-goals-feasible">Are Donald Trump&#8217;s Ambitious Bitcoin Goals Feasible?</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Vivek Ramaswamy's Strive Applies For 'Bitcoin Bond' ETF That Tracks MicroStrategy's Convertible Securities Market

Comments

Bank of Ireland Group

Bank of Ireland Group (BKRIF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga